Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Glomerulonephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02155803
What this trial is testing

ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study

Who this might be right for
SarcoidosisHypercalcemia Due to Sarcoidosis
Albany Medical College 10
Testing effectiveness (Phase 2)Looking for participantsNCT06155604
What this trial is testing

SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease

Who this might be right for
Lupus NephritisChronic Kidney Diseases
The University of Hong Kong 150
Not applicableUnknownNCT01126931
What this trial is testing

Wormwood in Chronic Progressive Disorders With Reduced Appetite

Who this might be right for
Cancer
University Hospital Freiburg 300
Testing effectiveness (Phase 2)Study completedNCT00914524
What this trial is testing

Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy

Who this might be right for
Chronic GlomerulonephritisDiabetic Nephropathy
Daiichi Sankyo Co., Ltd. 49
Testing effectiveness (Phase 2)Looking for participantsNCT07268638
What this trial is testing

Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Focal Segmental Glomerulosclerosis
Akebia Therapeutics 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04573478
What this trial is testing

Atrasentan in Patients With IgA Nephropathy

Who this might be right for
IgA NephropathyImmunoglobulin A Nephropathy
Novartis Pharmaceuticals 404
Very early researchEnrolling By InvitationNCT07750249
What this trial is testing

The MIMIGA Study is a Randomized, Double-blind, Placebo-controlled Crossover Trial Evaluating the Safety and Efficacy of SCFA vs. Placebo. Administered Orally Once Daily With Standard Care, it Aims to Prevent CKD Progression in Biopsy-proven IgA Nephropathy by Modulating the Gut Microbiome.

Who this might be right for
Primary IgA Nephropathy
University Hospital, Martin 120
Early research (Phase 1)WithdrawnNCT00816504
What this trial is testing

Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5

Who this might be right for
Focal Segmental Glomerulosclerosis
Northwell Health
Testing effectiveness (Phase 2)WithdrawnNCT05599815
What this trial is testing

Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Aldeyra Therapeutics, Inc.
Large-scale testing (Phase 3)Active Not RecruitingNCT05852938
What this trial is testing

Zigakibart in Adults With IgA Nephropathy

Who this might be right for
IgA NephropathyImmunoglobulin A Nephropathy
Novartis Pharmaceuticals 383
Testing effectiveness (Phase 2)Study completedNCT03373461
What this trial is testing

Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals 112
Large-scale testing (Phase 3)Ended earlyNCT03608033
What this trial is testing

Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy

Who this might be right for
IgA Nephropathy
Omeros Corporation 360
Not applicableUnknownNCT03801135
What this trial is testing

Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation

Who this might be right for
Humoral RejectionGuillain-Barre SyndromeMiller Fisher Syndrome+3 more
University Medical Centre Ljubljana 20
Post-approval studies (Phase 4)Looking for participantsNCT07030894
What this trial is testing

Nefecon and Ambrisentan in IgA Nephropathy

Who this might be right for
IgA NephropathyChronic Kidney DiseaseProteinuria
The First Hospital of Jilin University 129
Not applicableStudy completedNCT02493101
What this trial is testing

The Correlation of Periostin and Renal Pathology in Chronic Kidney Disease Patients

Who this might be right for
Lupus NephritisIgA Nephropathy
Chulalongkorn University 100
Post-approval studies (Phase 4)WithdrawnNCT00508898
What this trial is testing

The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria

Who this might be right for
Systemic Lupus ErythematosusNephritisProteinuria
Chinese University of Hong Kong
Testing effectiveness (Phase 2)Study completedNCT00446251
What this trial is testing

Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGA+1 more
University of Washington 14
Not applicableStudy completedNCT04389827
What this trial is testing

Global Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
The George Institute 5,999
Not applicableLooking for participantsNCT07330362
What this trial is testing

The Clinical Application of Artificial Intelligence Assisted Renal Biopsy Diagnosis System.

Who this might be right for
Chronic GlomerulonephritisChronic Kidney Disease
Zhujiang Hospital 2,900
Not applicableLooking for participantsNCT05036850
What this trial is testing

China Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
George (Beijing) Clinical Research Co. Ltd. 1,200
Next Page